AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. VNRX
  4. [EFFECT] VolitionRX Limited SEC Filing

[EFFECT] VolitionRX Limited SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 14, 2025 5:00 P.M.
Form: S-3
CIK: 0000093314
Company Name: VOLITIONRX LTD
File Number: 333-288508

Source:

Stock VNRX logo
Volitionrx

NYSE:VNRX

VNRX Rankings

#7434 Ranked by Market Cap
N/A Ranked by Dividends

VNRX Latest News

Aug 8, 2025
VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update
Aug 4, 2025
VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering
Jul 16, 2025
Nu.Q庐 Discover Expands Global Adoption and Epigenetic Innovation
Jul 8, 2025
Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes
Jun 12, 2025
Volition Announces MARS Consortium Clinical Study Suggests Nu.Q庐 H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure

VNRX Latest SEC Filings

Aug 6, 2025
[Form 4] VolitionRX Limited Insider Trading Activity
Aug 6, 2025
[Form 4] VolitionRX Limited Insider Trading Activity
Aug 5, 2025
[Form 4] VolitionRX Limited Insider Trading Activity
Aug 5, 2025
[Form 4] VolitionRX Limited Insider Trading Activity
Aug 5, 2025
[Form 4] VolitionRX Limited Insider Trading Activity

VNRX Stock Data

69.46M
83.43M
18.4%
20.49%
0.35%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
United States
HENDERSON